title: Antibodies in relation to gluten intake.
abstract: Serum reticulin, endomysial and gliadin antibody tests are used in serological screening and case finding of coeliac disease, as well as the novel tissue transglutaminase antibody test. None of these tests are 100% predictive, however. Reticulin/endomysial antibodies predict forthcoming coeliac disease in individuals with normal small-bowel mucosal morphology. The effect of a gluten-free diet can be monitored with serological tests. A positive test result often indicates an inadequate gluten-free diet. However, slight dietary transgressions and minor mucosal damages cannot always be revealed with the serological tests. Therefore, small-bowel mucosal biopsy remains the most sensitive method to monitor the effect of a gluten-free diet.
authors: Institute of Medical Technology, University of Tampere, Tampere, Finland. markku.maki@uta.fi
authors: M
authors: M
authors: Mäki
authors: S
authors: S
authors: Sulkanen
authors: P
authors: P
authors: Collin
mesh_terms: D001323:Autoantibodies / Q000097:blood*; D002446:Celiac Disease / Q000097:blood / Q000276:immunology*; D004032:Diet; D005903:Gliadin / Q000276:immunology; D005983:Glutens / Q000008:administration & dosage*; D006801:Humans; D009210:Myofibrils / Q000276:immunology; D012155:Reticulin / Q000276:immunology; D011503:Transglutaminases / Q000378:metabolism
chemical_list: D001323:Autoantibodies; D012155:Reticulin; D005983:Glutens; D005903:Gliadin; D011503:Transglutaminases